Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

High-frequency (20-MHz) high-intensity focused ultrasound (HIFU) system for dermal intervention: Preclinical evaluation in skin equivalents.

Bove T, Zawada T, Serup J, Jessen A, Poli M.

Skin Res Technol. 2019 Jan 8. doi: 10.1111/srt.12661. [Epub ahead of print]

PMID:
30620418
2.

Improving Measurement Efficiency of the Inner EAR Scale with Item Response Theory.

Jessen A, Ho AD, Corrales CE, Yueh B, Shin JJ.

Otolaryngol Head Neck Surg. 2018 Jun;158(6):1093-1100. doi: 10.1177/0194599818760528. Epub 2018 Mar 7.

PMID:
29512425
3.

Male reproductive suppression: not a social affair.

Zizzari ZV, Jessen A, Koene JM.

Curr Zool. 2017 Oct;63(5):573-579. doi: 10.1093/cz/zow089. Epub 2016 Aug 13.

4.

Native and Non-native Speakers' Brain Responses to Filled Indirect Object Gaps.

Jessen A, Festman J, Boxell O, Felser C.

J Psycholinguist Res. 2017 Oct;46(5):1319-1338. doi: 10.1007/s10936-017-9496-9.

PMID:
28508351
5.

Effect of patient-initiated versus fixed-interval telePRO-based outpatient follow-up: study protocol for a pragmatic randomised controlled study.

Schougaard LM, Mejdahl CT, Petersen KH, Jessen A, de Thurah A, Sidenius P, Lomborg K, Hjollund NH.

BMC Health Serv Res. 2017 Jan 26;17(1):83. doi: 10.1186/s12913-017-2015-8.

6.

In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines.

Ghadban T, Jessen A, Reeh M, Dibbern JL, Mahner S, Mueller V, Wellner UF, Güngör C, Izbicki JR, Vashist YK.

Int J Mol Med. 2016 Oct;38(4):1296-302. doi: 10.3892/ijmm.2016.2696. Epub 2016 Aug 3.

PMID:
27498942
7.

Morphological encoding in German children's language production: evidence from event-related brain potentials.

Jessen A, Fleischhauer E, Clahsen H.

J Child Lang. 2017 Mar;44(2):427-456. doi: 10.1017/S0305000916000118. Epub 2016 Mar 28.

PMID:
27018576
8.

Contacts to general practice and antidepressant treatment initiation after screening for anxiety and depression in patients with heart disease.

Larsen KK, Vestergaard CH, Schougaard LM, Larsen LP, Jessen A, May O, Hjøllund NH.

Dan Med J. 2016 Feb;63(2). pii: A5185.

PMID:
26836792
9.

AmbuFlex: tele-patient-reported outcomes (telePRO) as the basis for follow-up in chronic and malignant diseases.

Schougaard LM, Larsen LP, Jessen A, Sidenius P, Dorflinger L, de Thurah A, Hjollund NH.

Qual Life Res. 2016 Mar;25(3):525-34. doi: 10.1007/s11136-015-1207-0. Epub 2016 Jan 20.

10.

German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment.

Esser S, Kreuter A, Oette M, Gingelmaier A, Mosthaf F, Sautter-Bihl ML, Jongen J, Brockmeyer NH, Eldering G, Swoboda J, Postel N, Degen O, Schalk H, Jessen A, Knechten H, Thoden J, Stellbrink HJ, Schafberger A, Wieland U.

J Dtsch Dermatol Ges. 2015 Dec;13(12):1302-19. doi: 10.1111/ddg.12726. No abstract available.

PMID:
26612810
12.

Pyrosequencing for microbial identification and characterization.

Cummings PJ, Ahmed R, Durocher JA, Jessen A, Vardi T, Obom KM.

J Vis Exp. 2013 Aug 22;(78):e50405. doi: 10.3791/50405.

13.

HIV-associated lung cancer: survival in an unselected cohort.

Hoffmann C, Kohrs F, Sabranski M, Wolf E, Jaeger H, Wyen C, Siehl J, Baumgarten A, Hensel M, Jessen A, Schaaf B, Vogel M, Bogner J, Horst HA, Stephan C.

Scand J Infect Dis. 2013 Oct;45(10):766-72. doi: 10.3109/00365548.2013.810813. Epub 2013 Jul 23.

PMID:
23876190
14.

High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM.

Hoffmann C, Sahly H, Jessen A, Ingiliz P, Stellbrink HJ, Neifer S, Schewe K, Dupke S, Baumgarten A, Kuschel A, Krznaric I.

Infection. 2013 Oct;41(5):999-1003. doi: 10.1007/s15010-013-0501-4. Epub 2013 Jul 13.

PMID:
23852945
15.

Effectiveness and kinetics of ferrate as a disinfectant for ballast water.

Jessen A, Randall A, Reinhart D, Daly L.

Water Environ Res. 2008 Jun;80(6):561-9.

PMID:
18686931
16.

CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.

Oh DY, Jessen H, Kücherer C, Neumann K, Oh N, Poggensee G, Bartmeyer B, Jessen A, Pruss A, Schumann RR, Hamouda O.

PLoS One. 2008 Jul 23;3(7):e2747. doi: 10.1371/journal.pone.0002747.

17.

Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoring.

Wasmuth JC, Rodermann E, Voigt E, Vogel M, Lauenroth-Mai E, Jessen A, Burger D, Rockstroh JK.

Eur J Med Res. 2007 Jul 26;12(7):289-94.

PMID:
17933700
18.

Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.

Streeck H, Jessen H, Alter G, Teigen N, Waring MT, Jessen A, Stahmer I, van Lunzen J, Lichterfeld M, Gao X, Allen TM, Carrington M, Walker BD, Rockstroh JK, Altfeld M.

J Infect Dis. 2006 Sep 15;194(6):734-9. Epub 2006 Aug 15.

PMID:
16941338
19.

The appetite-suppressant effect of nicotine is enhanced by caffeine.

Jessen A, Buemann B, Toubro S, Skovgaard IM, Astrup A.

Diabetes Obes Metab. 2005 Jul;7(4):327-33.

PMID:
15955118
20.

Patient and family perceptions of hospital chaplains.

VandeCreek L, Thomas J, Jessen A, Gibbons J, Strasser S.

Hosp Health Serv Adm. 1991 Fall;36(3):455-67.

PMID:
10112579

Supplemental Content

Loading ...
Support Center